Fundraising FoxEndolipid Therapeutics
1 known investors
Find your way into Endolipid Therapeutics
Sign up to see every warm intro you have to Endolipid Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Endolipid Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Endolipid Therapeutics is a biotech developing SHBG-mimicking peptides aimed at reducing ectopic fat accumulation to treat conditions such as fatty liver disease and NASH, as well as cellulite. Its work spans therapeutic and dermocosmetic applications.
Founders & leadership
GD
Giacomo de SimoneCEO
DM
David M. SelvaCSO
RS
Rafael SimóCMO
AS
Agustí SolerCFO
Investors · 1
Frequently asked questions
- What does Endolipid Therapeutics do?
- Endolipid Therapeutics is a biotech developing SHBG-mimicking peptides aimed at reducing ectopic fat accumulation to treat conditions such as fatty liver disease and NASH, as well as cellulite. Its work spans therapeutic and dermocosmetic applications.
- Who are Endolipid Therapeutics's investors?
- Endolipid Therapeutics's investors include Capital Cell.